Patents by Inventor Ghulam N. Mir

Ghulam N. Mir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-pyridinecarbothioamides, processes for preparation thereof
    Patent number: 4950762
    Abstract: There are provided gastric antiulcer and cytoprotective substituted N-phenyl-2-pyridinecarbothioamides. The process for their production and formulation is disclosed.
    Type: Grant
    Filed: July 10, 1989
    Date of Patent: August 21, 1990
    Assignee: American Home Products Corporation
    Inventors: William A. Kinney, Amadeo A. Failli, Ghulam N. Mir
  • 2-pyridinecarbothioamides and pharmaceutical compositions comprising the same useful as anti ulcer agents
    Patent number: 4886821
    Abstract: There are provided gastric antiulcer and cytoprotective substituted N-phenyl-2-pyridinecarbothioamides. The process for their production and formulation is disclosed.
    Type: Grant
    Filed: November 23, 1987
    Date of Patent: December 12, 1989
    Assignee: American Home Products Corporation
    Inventors: William A. Kinney, Amadeo A. Failli, Ghulam N. Mir
  • Exogenously acidified antacid compositions having cytoprotective properties
    Patent number: 4857324
    Abstract: There are provided gastric cytoprotective exogenously acidified aluminum hydroxide antacid compositions which are formed by acidifying, for example, commercial liquid antacid suspensions containing aluminum hydroxide, antacid powders or solids containing aluminum hydroxide, or aluminum hydroxide gel, to the point where the aluminum hydroxide is solubilized. The solutuions may be formulated into liquid dosage forms or spray dried and formulated into solid dosage forms.
    Type: Grant
    Filed: December 21, 1987
    Date of Patent: August 15, 1989
    Assignee: American Home Products Corporation (Del.)
    Inventors: Ghulam N. Mir, Luis E. Borella, John F. DiJoseph, Gerald L. Reuter
  • Amidinoureas for treating irritable bowel syndrome
    Patent number: 4745131
    Abstract: 1-Phenyl-3N-alkyl amidinoureas are useful in the treatment of Irritable Bowel Syndrome.
    Type: Grant
    Filed: June 12, 1986
    Date of Patent: May 17, 1988
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John Yelnosky, Ghulam N. Mir
  • Amidinoureas for treating irritable bowel syndrome
    Patent number: 4701457
    Abstract: Amidinoureas are disclosed as useful for the treatment of irritable bowel syndrome.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: October 20, 1987
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John Yelnosky, Ghulam N. Mir
  • Amidinoureas for treating irritable bowel syndrome
    Patent number: 4611011
    Abstract: 1-Phenyl-3N-alkyl amidinoureas are useful in the treatment of irritable bowel syndrome.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: September 9, 1986
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, Ghulam N. Mir
  • Dysmenorrhea treatment
    Patent number: 4241087
    Abstract: Amidinoureas of the formula: ##STR1## when administered to females who suffer dysmenorrhea relieve discomfort and pain and prevent damage caused by abnormal uterine muscle spasms incident to dysmenorrhea.
    Type: Grant
    Filed: April 2, 1979
    Date of Patent: December 23, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: Ghulam N. Mir, Jacqueline B. Krebs, William L. Studt
  • Antidiarrheal triazinones
    Patent number: 4203985
    Abstract: New compositions containing as the principle active ingredient a 1,4-disubstituted-1,2-dihydro-1,3,5-triazin-2-one are used for remedial or prophylactic treatment of diarrhea and organic gastrointestinal disorders accompanied by diarrheal symptoms.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: May 20, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, George H. Douglas, Ghulam N. Mir, Dahyabhai M. Patel, Chong M. Won, Ronald L. Alioto
  • Antisecretory triazinones
    Patent number: 4203984
    Abstract: 1,4-disubstituted-1,2-dihydro-1,3,5-triazine-2-ones and their pharmaceutically acceptable salts are used in the prevention and treatment of gastrointestinal disorders associated with hyperactivity of the secretory glands in the gastrointestinal tract.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: May 20, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: George H. Douglas, Ghulam N. Mir, Chong M. Won, William L. Studt
  • Spasmolytic triazinones
    Patent number: 4203983
    Abstract: 1,4-disubstituted-1,2-dihydro-1,3,5-triazin-2-ones and their pharmaceutically acceptable salts are used in the control of abdominal spasticity especially the treatment of spasmodic conditions of the gastrointestinal tract by administering an effective amount of the triazinone in suitable pharmaceutical dosage forms including oral or parenteral dosage forms compounded with pharmaceutically acceptable carrier materials to patients having spasmodic syndromes.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: May 20, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, George H. Douglas, Ghulam N. Mir, Chong M. Won
  • Triazinones for veterinary use
    Patent number: 4198409
    Abstract: New compositions containing as the principle active ingredient a 1,4-disubstituted-1,2-dihydro-1,3,5-triazin-2-one are used for remedial or prophylactic treatment of diarrhea and organic gastrointestinal disorders accompanied by diarrheal symptoms.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: April 15, 1980
    Assignee: William H. Rorer, Inc.
    Inventors: John Yelnosky, George H. Douglas, Ghulam N. Mir, Dahyabhai M. Patel, Chong M. Won, Ronald L. Alioto